Shattuck Labs (STTK) Non Operating Income (2019 - 2026)
Shattuck Labs (STTK) reported Non Operating Income of $778000.0 for Q1 2026, up 39000.0% year-over-year from N/an in Q1 2025, and little changed quarter-over-quarter from $778000.0 in Q4 2025.
Shattuck Labs (STTK) Non Operating Income (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Non Operating Income data on file, last reported at $778000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $778000.0, up 39000.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 278.96% YoY), and the FY2025 annual result was $2.7 million, up 15976.47% from the prior year.
- Non Operating Income was little changed at $778000.0 in Q1 2026 per STTK's latest filing, from $778000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.5 million in Q1 2024 and troughed at -$4.2 million in Q4 2024.
- A 5-year average of $243823.5 and a median of $778000.0 in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2026: Non Operating Income slumped 493.64% in 2023, then jumped 39000.0% in 2026.
- A 5-year view of Non Operating Income shows it stood at $865000.0 in 2022, then tumbled by 493.64% to -$3.4 million in 2023, then declined by 23.7% to -$4.2 million in 2024, then jumped by 118.47% to $778000.0 in 2025, then changed by 0.0% to $778000.0 in 2026.
- Business Quant data shows STTK's Non Operating Income at $778000.0 in Q1 2026, $778000.0 in Q4 2025, and $660000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 778,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 778,000.00 |
| Dec 31, 2025 | 778,000.00 |
| Sep 30, 2025 | 660,000.00 |
| Jun 30, 2025 | 574,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | -4.21 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | -3.41 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 937,000.00 |
| Dec 31, 2022 | 865,000.00 |
| Sep 30, 2022 | 594,000.00 |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | -362,000.00 |
| Dec 31, 2021 | -2.02 Mn |
| Sep 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 914,000.00 |